Ovid Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
18 Mar 24 | BuyUS$50,364 | Jeremy Levin | Individual | 18,248 | US$2.76 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 24,135 | 0.034% |
Individual Insiders | 3,701,655 | 5.22% |
Public Companies | 7,531,996 | 10.6% |
General Public | 16,820,607 | 23.7% |
Hedge Funds | 18,935,696 | 26.7% |
Institutions | 23,930,538 | 33.7% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
7,531,996 | US$5.5m | 0% | no data | |||
6,117,400 | US$4.4m | 0% | 0.15% | |||
5,315,969 | US$3.9m | 0% | 0.09% | |||
4,195,289 | US$3.0m | -2.88% | no data | |||
3,853,818 | US$2.8m | -43.8% | 0.09% | |||
3,652,196 | US$2.7m | 0% | no data | |||
3,648,509 | US$2.7m | 0% | 0.39% | |||
2,976,308 | US$2.2m | -0.45% | no data | |||
2,500,000 | US$1.8m | 0% | 0.05% | |||
1,655,871 | US$1.2m | 0% | no data | |||
1,398,555 | US$1.0m | -5.2% | no data | |||
1,319,679 | US$958.6k | 0% | 2.75% | |||
1,260,079 | US$915.3k | 2.2% | no data | |||
1,155,647 | US$839.5k | 3.15% | no data | |||
983,200 | US$714.2k | 0% | 0.26% | |||
864,822 | US$628.2k | 0% | 0.26% | |||
485,940 | US$353.0k | -12.9% | 0.01% | |||
480,867 | US$349.3k | -2% | no data | |||
414,022 | US$300.7k | 4.61% | 0.03% | |||
412,825 | US$299.9k | -4.05% | no data | |||
342,169 | US$248.5k | 40.6% | no data | |||
259,500 | US$188.5k | 79.6% | 0.02% | |||
250,000 | US$181.6k | -27.5% | 0.14% | |||
229,553 | US$166.7k | -7.74% | no data | |||
222,893 | US$161.9k | 0% | no data |